|
Asano, N., Fujimoto, M., Yazawa, N., Shirasawa, S., Hasegawa, M., Okochi, H., Tamaki, K., Tedder, TF., Sato, S., 2004. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. American Journal of Pathology. 165(2):641-650.
Anonymous., 1984. Nomenclature for clusters of differentiation (CD) of antigens defined on human leukocyte populations. Bulletin of the World Health Organization. 62(5):809-811.
Anonymous., 1994. CD antigens 1993: an updated nomenclature for clusters of differentiation on human cells. IUIS/WHO Subcommittee on CD Nomenclature. Bulletin of the World Health Organization. 72(5):807-808.
Bradbury, LE., Kansas, GS., Levy, S., Evans, RL., Tedder, TF., 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. Journal of Immunology. 149(9):2841-2850.
Brandt, DS., Chu, E., 1997. Future challenges in the clinical development of thymidylate synthase inhibitor compounds. Oncology Research. 9(8):403-410.
Chu, E., Callender, MA., Farrell, MP., Schmitz, JC., 2003. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside. Cancer Chemotherapy & Pharmacology. 52 Suppl 1:S80-89.
Duschinsky, R., Pleven, E., Heidelberg, C., 1957. The synthesis of 5-fluorinated. Journal of the American Chemical Society. 79: 4559-4560.
Eckhardt, S., 2002. Recent progress in the development of anticancer agents. Current Medicinal Chemistry - Anti-Cancer Agents. 2(3):419-439.
Fujimoto, M., Poe, JC., Inaoki, M., Tedder, TF., 1998. CD19 regulates B lymphocyte responses to transmembrane signals. Seminars in Immunology. 10(4):267-277.
Fujii, S., Shimamoto, Y., Ohshimo, H., Imaoka, T., Motoyama, M., Fukushima, M., Shirasaka, T., 1989. Effects of the plasma concentration of 5-fluorouracil and the duration of continuous venous infusion of 5-fluorouracil with an inhibitor of 5-fluorouracil degradation on Yoshida sarcomas in rats. Japanese Journal of Cancer Research. 80(2):167-172.
Houghton, JA., Houghton, PJ., Wooten, RS., 1979. Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine. Cancer Research. 39(7 Pt 1):2406-2413.
Harrison, DE., Lerner, CP., 1991. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood. 78(5):1237-1240.
Hyeyoung, M., Encarnacion, MR., Dorshkind, K., 2005. Effects of aging on early B- and T-cell development. Immunological Reviews. 205 (1):7-17.
Hyams, JS., Batrus, CL., Grand, RJ., Sallan, SE., 1982. Cancer chemotherapy- induced lactose malabsorption in children. Cancer. 49:646–650.
Henderson, L., Wolfreys, A., Fedyk, J., Bourner, C., Windebank, S., 1998. The ability of the Comet assay to discriminate between genotoxins and cytotoxins. Mutagenesis. 13(1):89-94.
Heddle, JA., Hite, M., Kirkhart, B., Mavournin, K., MacGregor, JT., Newell, GW., Salamone, MF., 1983. The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutation Research. 123(1):61-118.
Inomata, A., Horii, I., Suzuki, K., 2002. 5-Fluorouracil-induced intestinal toxicity: what determines the severity of damage to murine intestinal crypt epithelia?. Toxicology Letters. 133(2-3):231-240.
Jeuniaux, C., 1964. "Free" chitin and "masked" chitin in invertebrate skeletal structures. Archives Internationales de Physiologie et de Biochimie. 72(2):329-330.
Kafetzopoulos, D., Martinou, A., Bouriotis, V., 1993. Bioconversion of chitin to chitosan: purification and characterization of chitin deacetylase from Mucor rouxii. Proceedings of the National Academy of Sciences of the United States of America. 90(7):2564-2568.
Kimura, Y., Okuda, H., 1999. Prevention by carp extract of myelotoxicity and gastrointestinal toxicity induced by 5-fluorouracil without loss of antitumor activity in mice. Journal of Ethnopharmacology. 68(1-3):39-45.
Kouchi, Y., Maeda, Y., Morinaga, H., Ohuchida, A., 1996. Immunotoxic effects of a new antineoplastic agent S-1 in mice. Comparison with S-1, UFT and 5-FU. Journal of Toxicological Sciences. 21 Suppl 3:691-701.
Kotsakis, A., Sarra, E., Peraki, M., Koukourakis, M., Apostolaki, S., Souglakos, J., Mavromanomakis, E., Vlachonikolis, J., Georgoulias, V., 2000. Docetaxel-induced lymphopenia in patients with solid tumors: a prospective phenotypic analysis. Cancer. 89(6):1380-1386.
Lowenthal, RM., Eaton, K., 1996. Toxicity of chemotherapy. Hematology – Oncology Clinics of North America. 10(4):967-990.
Mi, FL., Wong, TB., Shyu, SS., 1997. Sustained-release of oxytertraacyline from chitosanmicrospheres prepares by interfacial acylation and sprayhardening methods. Microencapsulation. 14:577-591.
Moore, BB., Moore, TA., Toews, GB., 2001. Role of T- and B-lymphocytes in pulmonary host defences. European Respiratory Journal. 18(5):846-856.
Nagae, Y., Miyamoto, H., Suzuki, Y., Shimizu, H., 1991. Effect of estrogen on induction of micronuclei by mutagens in male mice. Mutation Research. 263(1):21-26.
Ohe, T., 1996. Antigenotoxic activities of chitin and chitosan as assayed by sister chromatid exchange. Science of the Total Environment. 181(1):1-5.
Ohl, L., Bernhardt, G., Pabst, O., Forster, R., 2003. Chemokines as organizers of primary and secondary lymphoid organs. Seminars in Immunology. 15(5):249-255.
Ohuchida, A., Furukawa, A., Yoshida, J., Watanabe, M., Aruga, F., Miwa, Y., Shinkawa, K., Kinae, N., 1992. Micronucleus assays on 5-fluorouracil and 6-mercaptopurine with mouse peripheral blood reticulocytes. Mutation Research. 278(2-3):139-143.
Ostling, O., Johanson, KJ., 1984. Microelectrophoretic study of radiation -induced DNA damages in individual mammalian cells. Biochemical & Biophysical Research Communications. 123(1):291-298.
Pinedo, HM., Peters, GF., 1988. Fluorouracil: biochemistry and pharmacology. Journal of Clinical Oncology. 6(10):1653-64.
Park, PJ., Je, JY., Kim, SK., 2003. Free radical scavenging activity of chitooligosaccharides by electron spin resonance spectrometry. J Agric Food Chem. 51(6):4624-4627.
Pae, HO., Seo, WG., Kim, NY., Oh, GS., Kim, GE., Kim, YH., Kwak, HJ., Yun, YG., Jun, CD., Chung, HT., 2001. Induction of granulocytic differentiation in acute promyelocytic leukemia cells (HL-60) by water-soluble chitosan oligomer. Leukemia Research. 25(4):339-346.
Rydberg, B., Johanson, KJ., 1978. Estimation of DNA strand breaks in single mammalian cells. In Hanawalt PC, EC, Fox CF (eds): DNA repair mechanisms. New York: Academic Press: 465-468.
Schmid, W., 1975. The micronucleus test. Mutation Research. 31(1):9-15.
Shibata, Y., Foster, LA., Metzger, WJ., Myrvik, QN., 1997. Alveolar macrophages priming by intravenous administration of chitin particles, polymers of N-acetyl-glucosamine, in mice. Infection and Immunity 65:1734-1741.
Stopper, H., Kuhnel, A., Podschun, B., 1994. Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction. Biochemical & Biophysical Research Communications. 203(2):1124-1130.
Sato, S., Ono, N., Steeber, DA., Pisetsky, DS., Tedder, TF., 1996. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. Journal of Immunology. 157(10):4371-4378.
Singla, AK., Chawla, M., 2001. Chitosan: some pharmaceutical and biological aspects--an update. Journal of Pharmacy & Pharmacology. 53(8):1047-1067.
Schuetz, JD., Wallace, HJ., Diasio, RB., 1984. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity. Cancer Research. 44(4):1358-1363.
Sugimoto, K., Yoshida, M., Yata, T., Higaki, K., Kimura, T., 1998. Evaluation of poly(vinyl alcohol)-gel spheres containing chitosan as dosage form to control gastrointestinal transit time of drugs. Biological & Pharmaceutical Bulletin. 21(11):1202-1206.
Schipper, NG., Varum, KM.,Artursson, P., 1996. Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharmaceutical Research. 13(11):1686-1692.
Singh, NP., McCoy, MT., Tice, RR., Schneider, EL., 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research. 175(1):184-191.
Tedder, TF., Inaoki, M., Sato, S., 1997. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity. 6(2):107-111.
Tedder, TF., Isaacs, CM., 1989. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. Journal of Immunology. 143(2):712-717.
Tokoro, A., Kobayashi, M., Tatewaki, N., Suzuki, K., Okawa, Y., Mikami, T., Suzuki, S., Suzuki, M., 1989. Protective effect of N-acetyl chitohexaose on Listeria monocytogenes infection in mice. Microbiology & Immunology. 33(4):357-367.
Tsukada, K., Matsumoto, T., Aizawa, K., Tokoro, A., Naruse, R., Suzuki, S., Suzuki, M., 1990. Antimetastatic and growth-inhibitory effects of N-acetylchitohexaose in mice bearing Lewis lung carcinoma. Japanese Journal of Cancer Research. 81(3):259-265.
Takano, F., Tanaka, T., Aoi, J., Yahagi, N., Fushiya, S., 2004. Protective effect of (+)-catechin against 5-fluorouracil-induced myelosuppression in mice. Toxicology. 201(1-3):133-142.
Tice, RR., Andrews, PW., Hirai, O., Singh, NP., 1991. The single cell gel (SCG) assay: an electrophoretic technique for the detection of DNA damage in individual cells. Advances in Experimental Medicine & Biology. 283:157-164.
Yih, LH., Lee, TC., 2000. Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Research. 60(22): 6346-6352.
von Ledebur, M., Schmid, W., 1973. The micronucleus test. Methodological aspects. Mutation Research. 19(1):109-117.
Zhou, A., Matsuura, Y., Okuda, H., 1994. Chitosan augments cytoplytic activity of mouse lymphocytes. J. Tradit. Med.11:62-64.
|